Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain.

Spears W, Furgerson M, Sweetnam JM, Evans P, Gearing M, Fechheimer M, Furukawa R.

BMC Neurosci. 2014 Jun 14;15:74. doi: 10.1186/1471-2202-15-74.

2.

Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain.

Furgerson M, Fechheimer M, Furukawa R.

PLoS One. 2012;7(9):e44996. doi: 10.1371/journal.pone.0044996. Epub 2012 Sep 18.

3.

Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis.

Ha S, Furukawa R, Fechheimer M.

Neurobiol Aging. 2011 Dec;32(12):2287-98. doi: 10.1016/j.neurobiolaging.2010.01.003. Epub 2010 Feb 4.

4.

Coenzyme q induces tau aggregation, tau filaments, and Hirano bodies.

Santa-Mara I, Santpere G, MacDonald MJ, Gomez de Barreda E, Hernandez F, Moreno FJ, Ferrer I, Avila J.

J Neuropathol Exp Neurol. 2008 May;67(5):428-34. doi: 10.1097/NEN.0b013e31816fc9b6.

5.

Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.

Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, Lau LF, Yu WH, Duff KE.

J Neurosci. 2008 Mar 5;28(10):2624-32. doi: 10.1523/JNEUROSCI.5245-07.2008.

6.

Hirano body expression impairs spatial working memory in a novel mouse model.

Furgerson M, Clark JK, Crystal JD, Wagner JJ, Fechheimer M, Furukawa R.

Acta Neuropathol Commun. 2014 Sep 2;2:131. doi: 10.1186/s40478-014-0131-9.

7.
8.

Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains.

Satoh J, Tabunoki H, Ishida T, Saito Y, Arima K.

Neuropathol Appl Neurobiol. 2013 Dec;39(7):817-30. doi: 10.1111/nan.12036.

PMID:
23421764
9.

Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.

Park H, Kam TI, Kim Y, Choi H, Gwon Y, Kim C, Koh JY, Jung YK.

Hum Mol Genet. 2012 Jun 15;21(12):2725-37. doi: 10.1093/hmg/dds100. Epub 2012 Mar 13.

10.

[The role of actin in Alzheimer's disease].

Ostrowski M, Grzanka A, Izdebska M.

Postepy Hig Med Dosw (Online). 2005 Jun 3;59:224-8. Review. Polish.

11.

Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.

Padmanabhan J, Levy M, Dickson DW, Potter H.

Brain. 2006 Nov;129(Pt 11):3020-34. Epub 2006 Sep 20.

12.
13.

FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.

Bao XQ, Li N, Wang T, Kong XC, Tai WJ, Sun H, Zhang D.

PLoS One. 2013 Nov 4;8(11):e78033. doi: 10.1371/journal.pone.0078033. eCollection 2013.

14.

Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.

Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H, Hiltunen M.

Prog Neurobiol. 2013 Jul-Aug;106-107:33-54. doi: 10.1016/j.pneurobio.2013.06.002. Epub 2013 Jul 1. Review.

PMID:
23827971
15.

Requirements for Hirano body formation.

Griffin P, Furukawa R, Piggott C, Maselli A, Fechheimer M.

Eukaryot Cell. 2014 May;13(5):625-34. doi: 10.1128/EC.00044-14. Epub 2014 Mar 14.

16.

Transgenic mouse model for the formation of Hirano bodies.

Ha S, Furukawa R, Stramiello M, Wagner JJ, Fechheimer M.

BMC Neurosci. 2011 Oct 6;12:97. doi: 10.1186/1471-2202-12-97.

17.
18.

The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

Maccioni RB, Muñoz JP, Barbeito L.

Arch Med Res. 2001 Sep-Oct;32(5):367-81. Review.

PMID:
11578751
19.

Hirano bodies and related neuronal inclusions.

Hirano A.

Neuropathol Appl Neurobiol. 1994 Feb;20(1):3-11. Review.

PMID:
8208338
20.

Interaction of Tau with Fe65 links tau to APP.

Barbato C, Canu N, Zambrano N, Serafino A, Minopoli G, Ciotti MT, Amadoro G, Russo T, Calissano P.

Neurobiol Dis. 2005 Mar;18(2):399-408.

PMID:
15686969
Items per page

Supplemental Content

Write to the Help Desk